Multiple targeted tyrosine kinase inhibition in the clinic: All for one or one for all?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference36 articles.
1. The discovery of receptor tyrosine kinase: targets for cancer therapy;Gschwind;Cancer,2004
2. Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer;Baselga;J Clin Oncol,2005
3. Gefitinib- a novel targeted approach to treating cancer;Herbst;Nature Rev,2004
4. Epidermal Growth Facor Receptor Mutations, Small-Molecule Kinase Inhibitors, and Non-Small-Cell Lung Cancer: Current Knowledge and Future Directions;Pao;J Clin Oncol,2005
5. Haematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N Engl J Med,2002
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Antitumor pharmacological research in the era of personalized medicine;Acta Pharmacologica Sinica;2022-11-24
2. Some important inhibitors and mechanisms of rheumatoid arthritis;Chemical Biology & Drug Design;2022-01-11
3. Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation;Future Medicinal Chemistry;2017-07
4. Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview;Medicinal Research Reviews;2016-10-24
5. Antiangiogenic Effects of Topically Administered Multiple Kinase Inhibitor, Motesanib (AMG 706), on Experimental Choroidal Neovascularization in Mice;Journal of Ocular Pharmacology and Therapeutics;2015-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3